GrantForecasted — not yet open✓ Small businesses may apply
Impact of Immunotherapies on CNS Outcomes in People with HIV: Potential Benefits, Challenges and Risks
National Institutes of Health
Program funding
$2,000,000
- Opportunity #
- RFA-MH-27-110
- Agency
- National Institutes of Health
- ALN (CFDA)
- 93.242
- Status
- forecasted
- Posted
- Mar 16, 2026
- Funding instrument
- Grant
- Category
- Health
- Cost sharing required
- No
Who can apply
- •City or township governments
- •Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- •Private institutions of higher education
- •Small businesses
- •For profit organizations other than small businesses
- •Others (see text field entitled "Additional Information on Eligibility" for clarification)
- •State governments
- •Public and State controlled institutions of higher education
- •Public housing authorities/Indian housing authorities
- •Special district governments
- •Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- •County governments
- •Native American tribal governments (Federally recognized)
- •Native American tribal organizations (other than Federally recognized tribal governments)
- •Independent school districts
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;
Contact
Division of AIDS Research · NIMH.DAR.inquiries@nih.gov